Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1336 |
| Name of the vaccine | Typhax |
| Microbe | Bacteria |
| Disease name | Typhoid |
| Name of bacteria | Salmonella typhi |
| Type of vaccine | Conjugate |
| Nucleic acid content | DNA |
| Age | 18 to 55 years |
| Description of the vaccine | Investigational typhoid fever candidate vaccine. |
| Name of the manufacturer | Matrivax Research and Development Corporation |
| Name of the manufacturing country | NA |
| Year of manufacture | 2017 |
| Clinical Phase status | Clinical - Phase 1 |
| Bacterial strain | Gram negative bacteria. |
| Efficacy | NA |
| Vaccine formulation | Suspension for injection |
| Dosage | Two dose regimen. |
| Mechanism of action | Anti-Vi antibody. |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination dose (2 doses) |
| Interspecies transfer | NA |
| PubMed identifier | 31905228 |
| Clinical trial number | NCT03926455 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |